In the TCGA data, TNFAIP2 mRNA levels in 33 types of tumor tissues were also explored (Fig. 1) and all cancers expressed TNFAIP2. The highest TNFAIP2 level was observed in bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) and uterine corpus endometrial carcinoma (UCEC). The gene discussed is TNFAIP2; the disease is endocervical adenocarcinoma.